This protocol covers cutaneous leishmaniasis specifically caused by Leishmania braziliensis or Leishmania peruviana — two genetically closely related species that share a common treatment framework.
For lesions that meet specific clinical eligibility criteria, local treatment modalities are available as a first-line option.
The full protocol specifies which modalities apply, the relevant eligibility thresholds, and how they are sequenced — details that go beyond what is summarised here.
DOI: 10.1111/jtm.12089